| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Revenue | 221.6 | 192.9 |
| Gross profit | 164.5 | 137.1 |
| Profit before tax | -29.9 | -5.2 |
| Net income | -29.9 | -5.2 |
| EPS (diluted, $ a share) | $-0.90 | $-0.16 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
| Revenue, year on year | +14.9% |
|---|---|
| Gross margin | 74.2% |
| Operating margin | -14.7% |
10-Q filed with the SEC, NASDAQ: IRTC. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
iRhythm Holdings, Inc.: key numbers
- Share price
- $90.83Close, Nov 16
- Market cap
- $3.05B
- Shares outstanding
- 33.62MLatest SEC cover page
- Sector
- Industrial Applications and Services
- Industry
- Surgical & Medical Instruments & ApparatusSIC 3841
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from iRhythm Holdings, Inc.
All →iRhythm Holdings Executive Compensation
iRhythm Holdings adopted a new nonqualified Deferred Compensation Plan effective January 1, 2027, for eligible employees and non-employee directors. The plan allows participants, including named executive officers, to defer up to 80% of base salary and 100% of annual bonuses or cash fees into notionally invested accounts. While the plan is unfunded, the company intends to establish a trust to hold assets for these future obligations.
iRhythm Holdings Announces $200M Stock Buyback
iRhythm Holdings' board of directors has authorized a new share repurchase program to buy back up to $200 million of its outstanding common stock. The company plans to fund the repurchases using existing cash and cash equivalents and ongoing cash from operations. The authorization reflects management's confidence in the core business and growth opportunities following the recent acquisition of VitalConnect.
- Value
- $200M
iRhythm Holdings Financial Results
iRhythm Holdings reported Q3 2026 revenue of $221.6 million, a 14.9% year-over-year increase driven by strong volume demand for its Zio Monitor. The company also announced the completion of its acquisition of VitalConnect on October 5, 2026, and the closing of a new $300 million revolving credit facility.
- Term
- Q3 2026
“Our third quarter results reflect the continued strength of our core business. Demand for Zio Monitor remains robust, exceeding our expectations in the quarter, driven by volume growth across care settings and channels. We also continued to take meaningful steps forward with significant margin expansion, and consistent execution against our strategic priorities.”
Quentin Blackford, President and Chief Executive Officer
iRhythm Holdings Signs $238M M&A Deal with Vital Connect, Inc.
iRhythm Holdings completed its acquisition of Vital Connect, Inc. for $237.5 million in cash. The deal expands iRhythm's cardiac monitoring portfolio into mobile cardiac telemetry (MCT) and multi-vitals monitoring across ambulatory, inpatient, and hospital-to-home care settings.
- Value
- $238M
- Counterparty
- Vital Connect, Inc.
iRhythm Holdings M&A Deal with Vital Connect, Inc.
iRhythm Holdings provided a status update on its pending acquisition of Vital Connect, Inc., announcing that the HSR Act antitrust waiting period expired on September 18, 2026. The company now expects the transaction to close in early October 2026, subject to customary closing conditions.
- Counterparty
- Vital Connect, Inc.